PPARGC1A and diabetic cardiomyopathy: Consistent with the observation in NRCMs, in vivo, QLQX reversed the decreased expressions of PPARγ and PGC-1α which were caused by hyperglycemia-induced diabetic cardiomyopathy (Figure 5A).